These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1872300)

  • 1. Oral treatment of diabetes mellitus: the contribution of gliclazide. Proceedings of a symposium, September 23, 1989, Lisbon, Portugal.
    Am J Med; 1991 Jun; 90(6A):1S-88S. PubMed ID: 1872300
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of gliclazide in the treatment of non-insulin-dependent diabetes mellitus: a Canadian multicenter study.
    Mailhot J
    Clin Ther; 1993; 15(6):1060-8. PubMed ID: 8111803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 24-hour glycemic profile in type 2 diabetic patients treated with gliclazide modified release once daily.
    Guillausseau PJ; Greb W
    Diabetes Metab; 2001 Apr; 27(2 Pt 1):133-7. PubMed ID: 11353879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gliclazide therapy of NIDDM in the 90s. Proceedings of 1st International Diamicron Symposium, September 24, 1990, Montreal, Canada.
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S1-92. PubMed ID: 1686583
    [No Abstract]   [Full Text] [Related]  

  • 5. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
    Charbonnel BH; Matthews DR; Schernthaner G; Hanefeld M; Brunetti P;
    Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gliclazide, a better choice for type 2 diabetes.
    Tripathi BK
    J Assoc Physicians India; 1999 Oct; 47(10):1034. PubMed ID: 10778709
    [No Abstract]   [Full Text] [Related]  

  • 7. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).
    Kardas P
    Diabetes Obes Metab; 2005 Nov; 7(6):722-8. PubMed ID: 16219016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of short term hypoglycemic treatment with gliclazide and gliquidone on platelet function in patients with diabetes mellitus type II].
    Grzeszczak W; Strojek K
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():38-9. PubMed ID: 8516206
    [No Abstract]   [Full Text] [Related]  

  • 9. Gliclazide in the treatment of obese NIDDM patients.
    Kumar S; Keswani P; Bose BS; Agrawal JK
    J Assoc Physicians India; 1994 Feb; 42(2):176-7. PubMed ID: 7646644
    [No Abstract]   [Full Text] [Related]  

  • 10. Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitus--a double blind randomized study.
    Chugh SN; Dhawan R; Kishore K; Sharma A; Chugh K
    J Assoc Physicians India; 2001 Aug; 49():803-7. PubMed ID: 11837468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-insulin dependent diabetes. Role of gliclazide (diamicron)].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1995; ():313-22. PubMed ID: 7602890
    [No Abstract]   [Full Text] [Related]  

  • 12. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
    Kigawa Y; Oba K; Futami-Suda S; Norose J; Yasuoka H; Suzuki K; Ouchi M; Watanabe K; Suzuki T; Nakano H
    Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gliclazide and metformin combination in patients with type 2 diabetes. Preliminary data].
    Galeone F; Fiore G; Arcangeli A; Mannucci E
    Minerva Endocrinol; 1998 Sep; 23(3):71-5. PubMed ID: 10063324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [2-year data of large clinical comparative studies. Type 2 diabetes: lasting metabolic control with pioglitazone].
    MMW Fortschr Med; 2004 Jul; 146(29-30):48-9. PubMed ID: 15540563
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diamicron in the treatment of diabetes mellitus type 2].
    Balabolkin MI; Morozova TP; Chachiashvili MV
    Sov Med; 1987; (7):21-2. PubMed ID: 3317910
    [No Abstract]   [Full Text] [Related]  

  • 16. [The importance of gliclazide in clinical practice].
    Svoboda Z
    Vnitr Lek; 1988 Jun; 34(6):581-5. PubMed ID: 3414038
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of gliclazide in the treatment of early diabetic retinopathy].
    Cabral BV; Fernando R; Villegas-Cinco A; Icasas-Cabral E; Cinco L
    Therapie; 1985; 40(4):231-3. PubMed ID: 4024018
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral treatment of diabetes mellitus: the contribution of gliclazide.
    Colwell JA
    Am J Med; 1991 Jun; 90(6A):1S-2S. PubMed ID: 1872299
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary PC-1 and N-acetyl-beta-D-glucosaminidase activity in patients with type 2 diabetes treated with metformin, gliclazide or glibenclamide.
    Stefanović V; Antić S; Mitić-Zlatković M; Stojiljković S; Milojković M; Bogicević M; Vlahović P
    Ann Clin Biochem; 2003 May; 40(Pt 3):232-4. PubMed ID: 12803833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gliclazide: a new sulphonylurea.
    Sullivan JT; Smith RB
    N Z Med J; 1984 Jan; 97(747):22-3. PubMed ID: 6361631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.